FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 359:539-541 July 31, 2008 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

To the Editor: Glioblastoma is a malignant brain tumor with overall survival rates of less than 3.3% at 5 years.¹ Few effective treatments are available. The durability of a radiographically defined response to treatment is limited, and median survival is less than 2 years.

We are conducting a phase 1 trial of autologous dendritic-cell vaccination as adjunctive therapy in glioma, a study that has been approved by the institutional review board at the University of California, Los Angeles. All patients are treated with surgery, standard radiotherapy, and temozolomide, followed by vaccination with dendritic cells that are pulsed with an autologous . . . [Full Text of this Article]

This article has been cited by other articles:

• Ghulam Muhammad, A.K.M., Candolfi, M., King, G. D., Yagiz, K., Foulad, D., Mineharu, Y., Kroeger, K. M., Treuer, K. A., Nichols, W. S., Sanderson, N. S., Yang, J., Khayznikov, M., Van Rooijen, N., Lowenstein, P. R., Castro, M. G. (2009). Antiglioma Immunological Memory in Response to Conditional Cytotoxic/Immune-Stimulatory Gene Therapy: Humoral and Cellular Immunity Lead to Tumor Regression. Clin. Cancer Res. 15: 6113-6127 [Abstract] [Full Text]  
• Kamil, J. P., Hume, A. J., Jurak, I., Munger, K., Kalejta, R. F., Coen, D. M. (2009). Human papillomavirus 16 E7 inactivator of retinoblastoma family proteins complements human cytomegalovirus lacking UL97 protein kinase. Proc. Natl. Acad. Sci. USA 106: 16823-16828 [Abstract] [Full Text]  
• Candolfi, M., Yagiz, K., Foulad, D., Alzadeh, G. E., Tesarfreund, M., Muhammad, A.K.M. G., Puntel, M., Kroeger, K. M., Liu, C., Lee, S., Curtin, J. F., King, G. D., Lerner, J., Sato, K., Mineharu, Y., Xiong, W., Lowenstein, P. R., Castro, M. G. (2009). Release of HMGB1 in Response to Proapoptotic Glioma Killing Strategies: Efficacy and Neurotoxicity. Clin. Cancer Res. 15: 4401-4414 [Abstract] [Full Text]  
• Meyer, M. A., Wen, P. Y., Kesari, S. (2008). Malignant Gliomas in Adults. NEJM 359: 1850-1850 [Full Text]